Midostaurin in Advanced Systemic Mastocytosis

被引：49

作者：

Chandesris, Marie-Olivia ^{[1
]}

Damaj, Gandhi ^{[2
]}

Canioni, Danielle ^{[3
]}

Brouzes, Chantal ^{[3
]}

Lhermitte, Ludovic ^{[3
]}

Hanssens, Katia ^{[4
]}

Frenzel, Laurent ^{[3
]}

Cherquaoui, Zoubair ^{[3
]}

Durieu, Isabelle ^{[5
]}

Durupt, Stephane ^{[5
]}

Gyan, Emmanuel ^{[6
]}

Beyne-Rauzy, Odille ^{[7
]}

Launay, David ^{[8
]}

Faure, Cyril ^{[9
]}

Hamidou, Mohamed ^{[10
]}

Besnard, Sophie ^{[11
]}

Diouf, Momar ^{[12
]}

Schiffmann, Aurelie ^{[13
]}

Niault, Mathilde ^{[14
]}

Jeandel, Pierre-Yves ^{[15
]}

Ranta, Dana ^{[16
]}

Gressin, Remi ^{[17
]}

Chantepie, Sylvain ^{[2
]}

Barete, Stephane ^{[18
]}

Dubreuil, Patrice ^{[4
]}

Bourget, Philippe ^{[3
]}

Lortholary, Olivier ^{[3
]}

Hermine, Olivier ^{[19
]}

机构：

[1] French Natl Reference Ctr Mastocytosis CERE MAST, Paris, France

[2] Univ Lower Normandy, Sch Med, Caen, France

[3] Necker Univ Hosp, Paris, France

[4] Paoli Calmettes Inst, Marseille, France

[5] Lyon Sud Univ Hosp, Lyon, France

[6] Tours Univ Hosp, Tours, France

[7] Purpan Univ Hosp, Toulouse, France

[8] Lille Univ Hosp, Lille, France

[9] Vesoul Reg Univ Hosp, Vesoul, France

[10] Hotel Dieu Univ Hosp, Nantes, France

[11] Rennes Univ Hosp, Rennes, France

[12] Amiens Univ Hosp, Amiens, France

[13] St Eloi Univ Hosp, Montpellier, France

[14] Bretagne Sud Reg Hosp, Lorient, France

[15] Archet 1 Univ Hosp, Nice, France

[16] Nancy Univ Hosp, Nancy, France

[17] Grenoble Univ Hosp, Grenoble, France

[18] Tenon Univ Hosp, Paris, France

[19] Imagine Inst, Paris, France

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 26期

关键词：

D O I：

10.1056/NEJMc1515403

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2605 / 2607

页数：3

共 50 条

[21] RESPONSE TO AVAPRITINIB IN PATIENTS (PTS) WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM) WITH AND WITHOUT PRIOR MIDOSTAURIN THERAPY
Vannucchi, A. M.
Radia, D. H.
Drummond, M. W.
George, T. I.
Horny, H-P.
Gotlib, J.
Deininger, M. W.
Robinson, W. A.
Quiery, A. T.
Bose, P.
Hexner, E. O.
Winton, E.
Tugnait, M.
Kittler, O. Schmidt
Evans, E. K.
Lin, H-M.
Mar, B. G.
DeAngelo, D. J.
HAEMATOLOGICA, 2020, 105 : S69 - S70
[22] A case of aggressive systemic mastocytosis with erythroderma showing response to midostaurin
Padulla, G.
Bianchi, P. G.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S374 - S374
[23] MATCHING-ADJUSTED INDIRECT COMPARISONS OF AVAPRITINIB VERSUS MIDOSTAURIN AMONG PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS
Pilkington, H.
Smith, S.
Roskell, N.
Iannazzo, S.
VALUE IN HEALTH, 2022, 25 (01) : S24 - S24
[24] Treatment with midostaurin and/or cladribine in 151 advanced systemic mastocytosis patients and its impact on the associated hematologic neoplasms
Lubke, J.
Schwaab, J.
Naumann, N.
Schmid, A.
Steiner, L.
Metzgeroth, G.
Fabarius, A.
Hofmann, W. -K.
Reiter, A.
Jawhar, M.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 79 - 80
[25] Real-World Efficacy and Safety of the Multikinase/KIT Inhibitor Midostaurin in Patients with Advanced Systemic Mastocytosis
Luebke, J.
Naumann, N.
Brand, T.
Metzgeroth, G.
Fabarius, A.
Horny, H. -P
Sotlar, K.
Hofmann, W. -K
Schwaab, J.
Reiter, A.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 274 - 274
[26] Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis
Szudy-Szczyrek, Aneta
Bachanek-Mitura, Oliwia
Gromek, Tomasz
Chromik, Karolina
Mital, Andrzej
Szczyrek, Michal
Krupski, Witold
Szumilo, Justyna
Kandula, Zuzanna
Helbig, Grzegorz
Hus, Marek
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) : 1 - 13
[27] Midostaurin Synergizes with Nilotinib and Dasatinib Restoring SETD2 Expression and Activity in Advanced Systemic Mastocytosis
Monaldi, Cecilia
Mancini, Manuela
De Santis, Sara
Martelli, Margherita
Rondoni, Michela
Papayannidis, Cristina
Sartor, Chiara
Zanotti, Roberta
Bonifacio, Massimiliano
Grifoni, Federica
Bruno, Samantha
Curti, Antonio
Elena, Chiara
Pagano, Livio
Criscuolo, Marianna
Cavo, Michele
Soverini, Simona
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S334 - S334
[28] Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis
Stone, Richard M.
Manley, Paul W.
Larson, Richard A.
Capdeville, Renaud
BLOOD ADVANCES, 2018, 2 (04) : 444 - 453
[29] Loss of CD25 Expression in Advanced Systemic Mastocytosis Patients Treated with Midostaurin (PKC412)
Kunder, C. A.
Deangelo, D. J.
Gotlib, J. R.
Gitana, G.
Atwater, S. K.
George, T. I.
LABORATORY INVESTIGATION, 2012, 92 : 349A - 349A
[30] Loss of CD25 Expression in Advanced Systemic Mastocytosis Patients Treated with Midostaurin (PKC412)
Kunder, C. A.
Deangelo, D. J.
Gotlib, J. R.
Gitana, G.
Atwater, S. K.
George, T. I.
MODERN PATHOLOGY, 2012, 25 : 349A - 349A

← 1 2 3 4 5 →